Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults

Recruiting Observational Study
Melanoma Spitzoid Melanoma Congenital Nevi
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 30
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
University Hospital Tuebingen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The primary objective of this study is the identification of environmental and genetic factors involved in the risk and progression of melanoma in children, adolescents and young adults (CAYA). The secondary objectives are to generate a model integrating the genetic and environmental factors to estimate the risk of developing melanoma and improve the primary prevention of melanoma through evidence…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * confirmed melanoma * age until 30 years old Exclusion Criteria: * no available biological material * no signed informed consent
Contacts

Ines B Brecht, MD, PhD

+49707183773

ines.brecht@med.uni-tuebingen.de

CONTACT

Christopher Schroeder, MD

christopher.schroeder@med.uni-tuebingen.de

CONTACT